Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 06 October, 2024
Author: Getaka|Social: Getaka Financial Services X (Earlier Twitter) Profile Getaka Financial Services LinkedIn Logo
Stock Ticker - BSE: 540975 | NSE: ASTERDM

Aster DM Healthcare Ltd: Intrinsic Value and Fundamental Analysis

Share Price and Basic Stock Data

Last Updated: October 5, 2024, 10:34 pm

Market Cap 20,602 Cr.
Current Price 412
High / Low558/309
Stock P/E110
Book Value 83.8
Dividend Yield0.48 %
ROCE4.48 %
ROE3.13 %
Face Value 10.0
PEG Ratio34.20

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Aster DM Healthcare Ltd

Competitors of Aster DM Healthcare Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Global Longlife Hospital and Research Ltd 38.0 Cr. 36.261.7/27.0 24.70.00 %2.51 %4.72 % 10.0
Gian Lifecare Ltd 20.8 Cr. 20.129.0/18.55.01 19.00.00 %29.2 %24.6 % 10.0
Fortis Malar Hospitals Ltd 109 Cr. 58.2108/44.0 58.473.0 %3.29 %9.12 % 10.0
Family Care Hospitals Ltd 42.1 Cr. 7.7910.4/6.233.76 10.80.00 %15.4 %24.1 % 10.0
Dr Lalchandani Labs Ltd 8.45 Cr. 19.535.0/0.00 22.00.00 %2.68 %8.23 % 10.0
Industry Average23,544.21 Cr772.7760.8285.183.40%11.40%12.00%9.04

All Competitor Stocks of Aster DM Healthcare Ltd

Quarterly Result

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales2,2282,3912,3722,5042,6502,7282,6622,8163,1923,2623,2153,3173,711
Expenses1,9002,0702,0912,1622,2522,2672,3702,4982,7432,7572,8352,9473,155
Operating Profit328321281343397460292319449506380370556
OPM %15%13%12%14%15%17%11%11%14%16%12%11%15%
Other Income7309101222371810159-468
Interest627766616762697787969910299
Depreciation157153153156161170175189198219217227232
Profit before tax11512270135181250857117320673-5233
Tax %7%4%15%6%7%2%6%23%8%11%73%-197%10%
Net Profit10711760128168246805415918320-15209
EPS in Rs1.852.110.892.142.974.531.370.932.793.420.10-0.623.59

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales1,9222,8713,8765,2505,9316,7217,9638,6528,60810,25311,93313,505
Expenses1,6602,4213,3704,8055,5826,0896,8867,1877,5068,72010,30711,693
Operating Profit2614515064453496321,0771,4651,1031,5331,6261,812
OPM %14%16%13%8%6%9%14%17%13%15%14%13%
Other Income11192325453177-155-158535179-14
Interest454879189371204205391334307390395
Depreciation76111144243322298306586618641780895
Profit before tax15131030638108308410330205637535507
Tax %4%9%11%78%10%8%10%5%13%6%11%
Net Profit149284272898282367315178601475396
EPS in Rs7.264.697.000.202.525.326.595.542.9610.538.516.49
Dividend Payout %0%35%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-2023
YoY Net Profit Growth (%)90.60%-4.23%-97.06%1125.00%187.76%30.14%-14.17%-43.49%237.64%-20.97%
Change in YoY Net Profit Growth (%)0.00%-94.83%-92.83%1222.06%-937.24%-157.61%-44.31%-29.32%281.13%-258.61%

Aster DM Healthcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2013-2014 to 2022-2023.

Growth

Compounded Sales Growth
10 Years:3%
5 Years:-14%
3 Years:-25%
TTM:-18%
Compounded Profit Growth
10 Years:-3%
5 Years:-23%
3 Years:-4%
TTM:-23%
Stock Price CAGR
10 Years:%
5 Years:29%
3 Years:26%
1 Year:26%
Return on Equity
10 Years:9%
5 Years:9%
3 Years:9%
Last Year:3%

Last Updated: Unknown

Balance Sheet

Last Updated: Unknown

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Equity Capital125375389403403505505497497500500500
Reserves6545361,096171,4722,3272,7092,7752,8753,0803,5743,686
Borrowings5058861,0913,3212,7582,3522,7885,6054,8045,2826,0751,758
Other Liabilities8561,0971,8342,0032,1712,2962,9263,5283,4443,6614,68712,039
Total Liabilities2,1402,8944,4095,7436,8047,4798,92812,40511,62012,52114,83617,983
Fixed Assets8721,0872,2372,5073,5203,7384,2897,1246,7497,0099,0523,175
CWIP185357197358290402550736934998279170
Investments673393238223463458017
Other Assets1,0771,4421,9722,8392,9623,3024,0674,5113,8744,4705,42514,620
Total Assets2,1402,8944,4095,7436,8047,4798,92812,40511,62012,52114,83617,983

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity 2362033615376011,2231,5691,3141,834158
Cash from Investing Activity -439-775-1,136-522-702-658-333-563-951-878
Cash from Financing Activity 20357865446134-675-1,116-686-8171,053
Net Cash Flow-15-1226133-1101206566332

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Free Cash Flow-244.00-435.00505.00442.00347.00630.00-1.00-4.00-3.00-4.00-5.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days95868393798493100867228523
Inventory Days8471939210211111013812212961244
Days Payable2131761781871511501533032902671,400183
Cash Conversion Cycle-34-18-2-1304550-65-83-66-503-116
Working Capital Days82616968575957403840129297
ROCE %18%14%6%1%7%13%12%6%10%3%4%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters37.88%37.88%37.88%37.88%37.88%37.88%41.88%41.88%41.88%41.88%41.88%41.88%
FIIs10.80%10.95%11.03%11.44%11.77%42.49%38.63%38.82%40.22%41.00%33.48%27.08%
DIIs8.48%8.45%8.64%9.66%8.99%8.93%8.93%8.62%7.64%7.15%13.70%16.35%
Public42.36%42.24%41.99%40.57%40.91%10.25%10.12%10.26%9.85%9.61%10.59%14.38%
Others0.48%0.47%0.46%0.45%0.45%0.44%0.43%0.42%0.41%0.37%0.35%0.32%
No. of Shareholders87,80480,74680,42778,37480,91384,57382,12971,37967,67367,33180,9312,06,660

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HDFC Small Cap Fund - Regular Plan16,630,8862.57736.174,465,5292024-10-04272.43%
Franklin India Smaller Companies Fund4,465,5291.67197.674,465,5292024-10-040%
HDFC Childrens Gift Fund - Regular Plan3,600,0001.89159.354,465,5292024-10-04-19.38%
Quant Small Cap Fund1,758,4850.577.844,465,5292024-10-04-60.62%
Franklin India Opportunities Fund1,489,8392.6565.954,465,5292024-10-04-66.64%
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund1,242,1001.5454.984,465,5292024-10-04-72.18%
ICICI Prudential Smallcap Fund935,5720.5641.414,465,5292024-10-04-79.05%
ICICI Prudential Value Discovery Fund822,8080.0936.424,465,5292024-10-04-81.57%
Sundaram Services Fund639,3290.8828.34,465,5292024-10-04-85.68%
Sundaram Small Cap Fund609,6470.8826.994,465,5292024-10-04-86.35%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)2.608.5410.582.975.51
Diluted EPS (Rs.)2.608.5310.572.975.50
Cash EPS (Rs.)8.8725.1224.9615.9318.03
Book Value[Excl.RevalReserv]/Share (Rs.)100.7089.8190.1577.1466.95
Book Value[Incl.RevalReserv]/Share (Rs.)100.7089.8190.1577.1466.95
Revenue From Operations / Share (Rs.)74.05238.89206.21173.19174.94
PBDIT / Share (Rs.)12.0732.9030.8522.3925.93
PBIT / Share (Rs.)7.6617.2817.979.9614.20
PBT / Share (Rs.)5.4610.6912.804.056.61
Net Profit / Share (Rs.)4.469.4912.083.516.30
NP After MI And SOA / Share (Rs.)2.598.5110.582.975.54
PBDIT Margin (%)16.2913.7714.9612.9214.82
PBIT Margin (%)10.347.238.715.758.11
PBT Margin (%)7.364.476.202.343.77
Net Profit Margin (%)6.023.975.852.023.60
NP After MI And SOA Margin (%)3.493.565.121.713.16
Return on Networth / Equity (%)2.8310.4313.304.389.54
Return on Capital Employeed (%)5.718.449.935.868.14
Return On Assets (%)0.712.854.191.262.22
Long Term Debt / Equity (X)0.090.320.370.520.65
Total Debt / Equity (X)0.140.560.550.560.85
Asset Turnover Ratio (%)0.220.180.140.090.12
Current Ratio (X)1.251.061.151.141.10
Quick Ratio (X)1.250.770.860.860.84
Interest Coverage Ratio (X)5.464.995.973.793.60
Interest Coverage Ratio (Post Tax) (X)2.962.443.341.591.93
Enterprise Value (Cr.)21464.8514334.7212129.548918.867516.57
EV / Net Operating Revenue (X)5.801.201.181.040.86
EV / EBITDA (X)35.618.727.918.025.80
MarketCap / Net Operating Revenue (X)5.531.010.950.790.54
Price / BV (X)4.482.962.482.021.65
Price / Net Operating Revenue (X)5.531.010.950.790.54
EarningsYield0.010.030.050.020.05

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Aster DM Healthcare Ltd as of October 6, 2024 is: ₹289.91

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of October 6, 2024, Aster DM Healthcare Ltd is Overvalued by 29.63% compared to the current share price ₹412.00

Intrinsic Value of Aster DM Healthcare Ltd as of October 6, 2024 is: ₹299.23

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of October 6, 2024, Aster DM Healthcare Ltd is Overvalued by 27.37% compared to the current share price ₹412.00

Last 5 Year EPS CAGR: 3.22%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a low average Cash Conversion Cycle of -63.58, which is a positive sign.
  2. The company has shown consistent growth in sales (6.58 cr) and profit (320.42 cr) over the years.
  1. The stock has a low average ROCE of 7.83%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 83.08, which may not be favorable.
  3. The company has higher borrowings (3,102.08) compared to reserves (2,066.75), which may suggest financial risk.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Aster DM Healthcare Ltd:
    1. Net Profit Margin: 6.02%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 5.71% (Industry Average ROCE: 11.4%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 2.83% (Industry Average ROE: 12%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 2.96
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.25
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 110 (Industry average Stock P/E: 60.82)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.14
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Aster DM Healthcare Ltd. is a Public Limited Listed company incorporated on 18/01/2008 and has its registered office in the State of Kerala, India. Company’s Corporate Identification Number(CIN) is L85110KA2008PLC147259 and registration number is 021703. Currently Company is involved in the business activities of Retail sale of pharmaceutical and medical goods, cosmetic and toilet articles in specialized stores. Company’s Total Operating Revenue is Rs. 1116.47 Cr. and Equity Capital is Rs. 497.22 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Hospitals & Medical ServicesAwfis, 2nd Floor, Renaissance Centra, 27 & 27/1, Mission Road, Bengaluru Kerala 560027cs@asterdmhealthcare.com
http://www.asterdmhealthcare.in
Management
NamePosition Held
Dr. Azad MoopenFounder Chairman & Mng. Director
Ms. Alisha MoopenDeputy Managing Director
Mr. Daniel Robert MintzNon Executive Director
Mr. T J WilsonNon Executive Director
Mr. Shamsudheen Bin Mohideen Mammu HajiNon Executive Director
Dr. James MathewIndependent Director
Mr. Emmanuel David GootamIndependent Director
Ms. Purana Housdurgamvijaya DeeptiIndependent Director
Mr. Chenayappillil John GeorgeIndependent Director
Mr. Wayne Earl KeathleyIndependent Director

FAQ

What is the latest fair value of Aster DM Healthcare Ltd?

The latest fair value of Aster DM Healthcare Ltd is ₹289.91.

What is the Market Cap of Aster DM Healthcare Ltd?

The Market Cap of Aster DM Healthcare Ltd is 20,602 Cr..

What is the current Stock Price of Aster DM Healthcare Ltd as on 05 October 2024?

The current stock price of Aster DM Healthcare Ltd as on 05 October 2024 is ₹412.

What is the High / Low of Aster DM Healthcare Ltd stocks in FY 2024?

In FY 2024, the High / Low of Aster DM Healthcare Ltd stocks is 558/309.

What is the Stock P/E of Aster DM Healthcare Ltd?

The Stock P/E of Aster DM Healthcare Ltd is 110.

What is the Book Value of Aster DM Healthcare Ltd?

The Book Value of Aster DM Healthcare Ltd is 83.8.

What is the Dividend Yield of Aster DM Healthcare Ltd?

The Dividend Yield of Aster DM Healthcare Ltd is 0.48 %.

What is the ROCE of Aster DM Healthcare Ltd?

The ROCE of Aster DM Healthcare Ltd is 4.48 %.

What is the ROE of Aster DM Healthcare Ltd?

The ROE of Aster DM Healthcare Ltd is 3.13 %.

What is the Face Value of Aster DM Healthcare Ltd?

The Face Value of Aster DM Healthcare Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Aster DM Healthcare Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE